Four years after it was sold for $155 million, Chicago employee benefits firm Maestro Health will be sold again, this time for $22 million.
New York City-based Marpai Inc. (Nasdaq: MRAI) said it's buying Maestro Health for $22.1 million that will be payable in cash on April 1, 2024.
Marpai is a third-party administrator that uses artificial intelligence to bring health care benefits to the self-insured employer market in the United States and Israel. Maestro is a TPA that services more than 80…
